Recent Finacing
Recent Raise
DOPPL operates a fully automated organoid platform combining diverse proprietary organ and disease organoid models with a clinical biobase to enable large-scale preclinical drug testing and personalized discovery.
Focus Areas
Recent Investors
Total Raised
Funding round
Investor